Pansoral (Choline Salicylate, Cetalkonium Chloride)

Choline Salicylate and Cetalkonium Chloride, the active ingredient in Pansoral, is a NSAID and antiseptic presented as an oral dosage form for oral use. It provides symptomatic relief of sore throat and oral mucosal inflammation in adults and children.

GNH USA supplies Pansoral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pansoral, containing choline salicylate and cetalkonium chloride, is used to manage inflammatory and infectious conditions of the oral cavity.

- Sore throat: reduces pain and inflammation in the pharyngeal mucosa. - Oral mucosal inflammation: alleviates swelling and discomfort in inflamed oral tissues. - Oral infections: provides antiseptic action to help control microbial growth in the mouth.

Common Side Effects: - Altered taste: transient metallic or bitter sensation in the mouth. - Mild nausea: occasional stomach upset after administration. - Oral irritation: transient burning or tingling at the site of contact. - Dyspepsia: mild indigestion or heartburn.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Severe gastrointestinal bleeding: black stools or vomiting of blood. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin blistering and mucosal involvement.

Before using Pansoral, consider the following precautions: - Assess allergy history: avoid if known hypersensitivity to salicylates or cetalkonium chloride. - Monitor for gastrointestinal irritation: advise patients to report persistent stomach pain or bleeding. - Use with caution in children: follow pediatric dosing guidance and avoid excessive use. - Avoid concurrent anticoagulants: increased risk of bleeding when combined with warfarin or similar agents. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Pansoral may interact with other medicines as follows:

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or salicylates: additive gastrointestinal toxicity. - Methotrexate: reduced renal clearance may increase toxicity.

Moderate Interactions (Monitor Closely): - Corticosteroids: heightened risk of gastrointestinal ulceration. - Selective serotonin reuptake inhibitors (SSRIs): potential for increased bleeding.